After striking a pact to bolster intravenous solution supplies in the U.S. last year, California's ICU Medical has run into a ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46 th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter's chief financial ...

Baxter International Inc. BAX is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the ...

Baxter International Inc. (NYSE:BAX – Get Free Report) has been assigned an average recommendation of “Hold” from the ten brokerages that are covering the stock, MarketBeat.com reports. One equities ...

Baxter International Inc. closed 29.99% short of its 52-week high of $44.01, which the company reached on March 8th.

Outlook and Future Plans: Baxter International Inc. completed the sale of its Kidney Care business and has reaffirmed its commitment to the financial objectives for 2025. The company anticipates 4 ...

Deerfield, Illinois-based Baxter International Inc. (BAX) functions as a healthcare company providing medical products and therapies. Valued at $16.2 billion by market cap, the company develops ...

Brent Shafer, who was appointed as Baxter’s Chair and Interim CEO in February 2025, has served as the Chairman and CEO of Cerner Corporation from 2018 to 2021. Nancy Schlichting, the retired President ...